Latest Breaking News On - Annual genetic medicines - Page 1 : comparemela.com

Editas Medicine Announces First Quarter 2024 Results and Business Updates

Editas Medicine Announces First Quarter 2024 Results and Business Updates
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkUnited kingdomCristi barnettGregory whiteheadVivo hemoglobinopathiesEmmanuelle charpentierBristol myers squibbGilmore oneillLas vegasEditas medicine incBroad institute casUniversity of viennaVertex pharmaceuticals incorporatedGenetic medicines forumHarvard university cas

Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events

CAMBRIDGE, Mass., May 02, 2024 Editas Medicine, Inc. , a clinical-stage gene editing company, today announced that it will host a conference call and webcast on Wednesday, May 8, 2024, at 8:00.

United kingdomNew yorkUnited statesLas vegasHarvard university casBroad instituteGenetic medicines forumAmerica health care conferenceEditas medicine incBroad institute casEditas medicine earnings conferenceEditas medicineMarkets global healthcare conferenceAnnual genetic medicinesHarvard university

REGENXBIO to Participate in Chardan s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

REGENXBIO to Participate in Chardan s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Chris brinzeyDana cormackCorporate communicationsAnnual genetic medicinesCell therapy manufacturing summitGene therapyEvery stage

MeiraGTx to Participate in Upcoming Investor Conferences

LONDON and NEW YORK, April 24, 2024 MeiraGTx Holdings plc , a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., President and Chief.

United statesCity ofUnited kingdomLas vegasGoldman sachsMeiragtx holdingsAlexandria forbesChief executive officerAnnual genetic medicinesCell therapy manufacturing summitSecurities healthcare conferenceAnnual global healthcare conferenceQuality control

Passage Bio to Present at Chardan s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

PHILADELPHIA, April 22, 2024 Passage Bio, Inc. , a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that.

United statesMike beyerStuart hendersonWilliam chouEden fucciPassage bio incSam brown incHealthcare communicationsAnnual genetic medicinesCell therapy manufacturing summitPassage bioBio media